As obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a role.

Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid ...

The KAER framework is designed to help primary care providers partner with older adults to engage in shared decision-making ...

A Carnegie Mellon University-led team of researchers has secured an award of up to $34.9 million(opens in new window) from ...

Parcel Health stands out as a key player in providing innovative packaging solutions for compounding pharmacies. Parcel Health's eco-friendly paper pill bottles ensure the stability and integrity of ...

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...

Bio-Path Holdings, Inc., (NASDAQ:BPTH) stock is trading higher on Tuesday with a strong session volume of 25.89 million ...

LONDON and NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicine company, today announced a poster presentation at ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

Like women, men should check their chests regularly for symptoms. As with all cancers, early detection is key. However, a ...

“Obesity in anyone and especially for pregnant women ... With tailored joint alignment and personalized treatment plans, ...